Advertisement
MET or MFC or PUK
Which Stock Would AI Choose? MetLife (MET) vs. Manulife Financial (MFC) vs. Prudential plc (PUK) Stock Comparison
Key Takeaways
- MET reported strong Q1 2026 results with adjusted EPS up 23% year-over-year, beating estimates, supported by higher investment income and volume growth.
- MFC has shown robust YTD gains of approximately 10-11%, reaching near 52-week highs around $40, driven by positive market momentum ahead of upcoming Q1 earnings.
- PUK delivered 10% growth in Q1 new business profit to $686 million, with APE sales up 6%, reflecting strength in Asia and Africa markets.
- All three stocks operate in life insurance but differ geographically: MET U.S.-focused, MFC Canada/Asia, PUK Asia/Africa.
- Recent momentum favors MFC with strongest YTD performance, while MET and PUK show stable growth post-earnings updates.
- Dividend yields remain attractive across the board, with MET at around 3%.
Introduction
This stock comparison examines MET, MFC, and PUK, three prominent players in the global life insurance sector. These companies provide insurance, annuities, and asset management services, navigating interest rate shifts, investment returns, and regional economic dynamics. Traders seeking momentum plays and investors focused on dividends or long-term stability will find value in analyzing their recent performances, geographic exposures, and relative valuations in today's market environment, where insurance stocks balance growth and yield amid volatility.
MET Overview and Recent Performance
MetLife, Inc. (MET) is a leading U.S.-based provider of life insurance, annuities, group benefits, and asset management, serving individual and institutional clients globally. In recent market activity, MET shares traded around $78, with a market cap of approximately $50 billion and a P/E ratio of 15.1. The stock has shown resilience, posting a modest YTD return of about 0.4% amid broader sector pressures.
Key influences include robust Q1 2026 results, where adjusted earnings per share rose 23% year-over-year to $2.42, surpassing estimates by 7.6%. Premiums, fees, and other revenues increased 5% to $14.3 billion, bolstered by higher net investment income (up 10%) from strong private equity returns and volume growth. Book value per share climbed 8%, and the company returned over $1.1 billion to shareholders via dividends and buybacks, including a 4.4% dividend hike. Sentiment has been positive on strategic initiatives and favorable underwriting, though shares dipped slightly post-earnings on revenue misses.
MFC Overview and Recent Performance
Manulife Financial Corporation (MFC) is a Canada-headquartered multinational offering financial advice, insurance, and wealth management, with significant operations in Asia and the U.S. under John Hancock. Recently, shares hit near 52-week highs around $40, boasting a YTD return of roughly 10.7% and a market cap exceeding $65 billion.
In recent weeks, MFC has benefited from strong capital returns and analyst upgrades ahead of Q1 2026 earnings on May 13. Prior Q4 2025 results showed core earnings growth, with EPS beating estimates. The stock's momentum reflects robust performance in wealth management and Asia, where demand for retirement solutions drives premiums. Dividend consistency and share repurchases have supported investor confidence, with the stock outperforming peers YTD amid favorable interest rate expectations boosting net interest income (NII, or earnings from interest-bearing assets).
PUK Overview and Recent Performance
Prudential plc (PUK) focuses on life and health insurance plus asset management across Asia and Africa, targeting high-growth emerging markets. Shares have traded around $31, with a flat YTD performance near 0.9% and a 52-week range of $22-$34.
Recent developments highlight Q1 2026 strength, with new business profit up 10% to $686 million and annual premium equivalent (APE, a measure of new policy value) sales rising 6% to $1,823 million. Margins expanded to 38%, driven by consistent double-digit growth in key segments. The company announced a $1.2 billion buyback and expects over $7 billion in shareholder returns through 2027. Sentiment benefits from Asia's demographic tailwinds and strategic stake increases, though currency fluctuations and market volatility have tempered gains.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases the platform's top-performing AI trading bots, curated from hundreds available that trade thousands of tickers across diverse strategies, timeframes, and sectors like semiconductors, industrials, ETFs, and finance. Only the most suitable for current conditions—based on metrics like annualized returns up to 285%, win rates of 50-88%, and profit factors exceeding 7—earn a spot among the 25 featured out of 351 total bots. These include signal agents for real-time trades, virtual agents with customizable risk management (e.g., TP/SL corridors), and brokerage-integrated options, often outperforming the S&P 500 in volatile markets. Explore these high-conviction bots to enhance your trading edge.
Head-to-Head Comparison
MET, MFC, and PUK share life insurance cores but diverge in models: MET emphasizes U.S. group benefits and annuities, MFC balances wealth management with Asia growth, and PUK prioritizes emerging-market health/life sales.
Growth drivers contrast: PUK's 10% new business profit rise edges MET's EPS surge, while MFC leads momentum. Recent performance shows MFC strongest YTD (~11%), MET stable (~0.4%), PUK flat. Risks include U.S. rate sensitivity for MET, Asia geopolitics for MFC/PUK. Valuations are comparable (P/E ~15), with all offering ~2-3% yields; MFC trades at a premium on momentum, PUK potentially undervalued on growth.
Tickeron AI Verdict
Tickeron’s AI currently favors MFC due to superior recent momentum, YTD outperformance, and positioning ahead of earnings, coupled with diversified Asia exposure and strong capital returns. While MET offers post-earnings stability and PUK emerging-market catalysts, MFC's trend consistency suggests higher probability of near-term relative gains in the current environment.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MET’s FA Score shows that 3 FA rating(s) are green whileMFC’s FA Score has 1 green FA rating(s), and PUK’s FA Score reflects 0 green FA rating(s).
- MET’s FA Score: 3 green, 2 red.
- MFC’s FA Score: 1 green, 4 red.
- PUK’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MET’s TA Score shows that 4 TA indicator(s) are bullish while MFC’s TA Score has 3 bullish TA indicator(s), and PUK’s TA Score reflects 5 bullish TA indicator(s).
- MET’s TA Score: 4 bullish, 5 bearish.
- MFC’s TA Score: 3 bullish, 5 bearish.
- PUK’s TA Score: 5 bullish, 6 bearish.
Price Growth
MET (@Life/Health Insurance) experienced а +0.43% price change this week, while MFC (@Life/Health Insurance) price change was -0.79% , and PUK (@Life/Health Insurance) price fluctuated -0.63% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.63%. For the same industry, the average monthly price growth was +2.75%, and the average quarterly price growth was +3.36%.
Reported Earning Dates
MET is expected to report earnings on Aug 05, 2026.
MFC is expected to report earnings on Aug 05, 2026.
Industries' Descriptions
@Life/Health Insurance (+0.63% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| MET | MFC | PUK | |
| Capitalization | 55.3B | 66.9B | 33.2B |
| EBITDA | N/A | N/A | N/A |
| Gain YTD | 10.499 | 11.053 | -13.328 |
| P/E Ratio | 16.94 | 16.47 | 8.80 |
| Revenue | 76B | 53.2B | 27.4B |
| Total Cash | 121B | 25B | N/A |
| Total Debt | 21.1B | 13.4B | 5.33B |
MET | MFC | PUK | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 80 | 7 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 32 Undervalued | 42 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 41 | 12 | 100 | |
SMR RATING 1..100 | 96 | 98 | 54 | |
PRICE GROWTH RATING 1..100 | 30 | 46 | 61 | |
P/E GROWTH RATING 1..100 | 29 | 50 | 87 | |
SEASONALITY SCORE 1..100 | 50 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (32) in the Life Or Health Insurance industry is in the same range as MFC (42) in the Life Or Health Insurance industry, and is in the same range as PUK (50) in the Multi Line Insurance industry. This means that MET's stock grew similarly to MFC’s and similarly to PUK’s over the last 12 months.
MFC's Profit vs Risk Rating (12) in the Life Or Health Insurance industry is in the same range as MET (41) in the Life Or Health Insurance industry, and is significantly better than the same rating for PUK (100) in the Multi Line Insurance industry. This means that MFC's stock grew similarly to MET’s and significantly faster than PUK’s over the last 12 months.
PUK's SMR Rating (54) in the Multi Line Insurance industry is somewhat better than the same rating for MET (96) in the Life Or Health Insurance industry, and is somewhat better than the same rating for MFC (98) in the Life Or Health Insurance industry. This means that PUK's stock grew somewhat faster than MET’s and somewhat faster than MFC’s over the last 12 months.
MET's Price Growth Rating (30) in the Life Or Health Insurance industry is in the same range as MFC (46) in the Life Or Health Insurance industry, and is in the same range as PUK (61) in the Multi Line Insurance industry. This means that MET's stock grew similarly to MFC’s and similarly to PUK’s over the last 12 months.
MET's P/E Growth Rating (29) in the Life Or Health Insurance industry is in the same range as MFC (50) in the Life Or Health Insurance industry, and is somewhat better than the same rating for PUK (87) in the Multi Line Insurance industry. This means that MET's stock grew similarly to MFC’s and somewhat faster than PUK’s over the last 12 months.
| MET | MFC | PUK | |
|---|---|---|---|
| RSI ODDS (%) | 1 day ago 64% | 1 day ago 61% | 1 day ago 67% |
| Stochastic ODDS (%) | 1 day ago 61% | 1 day ago 55% | 1 day ago 69% |
| Momentum ODDS (%) | 1 day ago 65% | 1 day ago 63% | 1 day ago 63% |
| MACD ODDS (%) | 1 day ago 65% | 1 day ago 64% | 1 day ago 61% |
| TrendWeek ODDS (%) | 1 day ago 59% | 1 day ago 51% | 1 day ago 71% |
| TrendMonth ODDS (%) | 1 day ago 50% | 1 day ago 54% | 1 day ago 73% |
| Advances ODDS (%) | 1 day ago 64% | 1 day ago 63% | 13 days ago 59% |
| Declines ODDS (%) | 10 days ago 53% | 4 days ago 51% | 4 days ago 71% |
| BollingerBands ODDS (%) | 1 day ago 60% | 1 day ago 49% | 1 day ago 67% |
| Aroon ODDS (%) | 1 day ago 50% | 1 day ago 51% | 1 day ago 71% |
Advertisement
PUK and
Correlation & Price change
A.I.dvisor indicates that over the last year, PUK has been loosely correlated with MFC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PUK jumps, then MFC could also see price increases.